Symbol="RVMD"
AssetType="Common Stock"
Name="Revolution Medicines Inc"
Description="Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California."
CIK="1628171"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="700 SAGINAW DR, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2805600000"
EBITDA="-271241984"
PERatio="None"
PEGRatio="None"
BookValue="8.96"
DividendPerShare="0"
DividendYield="0"
EPS="-2.97"
RevenuePerShareTTM="0.406"
ProfitMargin="0"
OperatingMarginTTM="-7.91"
ReturnOnAssetsTTM="-0.196"
ReturnOnEquityTTM="-0.345"
RevenueTTM="34816000"
GrossProfitTTM="-217693000"
DilutedEPSTTM="-2.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.074"
AnalystTargetPrice="31"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="72.24"
PriceToBookRatio="3.162"
EVToRevenue="53.04"
EVToEBITDA="-6.63"
Beta="1.438"
num_52WeekHigh="31.37"
num_52WeekLow="17.03"
num_50DayMovingAverage="25.4"
num_200DayMovingAverage="23.32"
SharesOutstanding="106313000"
DividendDate="None"
ExDividendDate="None"
symbol="RVMD"
open="26.30"
high="26.84"
low="26.20"
price="26.39"
volume="490112.00"
latest_trading_day="2023-07-07"
previous_close="26.20"
change="0.19"
change_percent="0.7252%"
aroon_positive_momentum_days="47"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="47"
Volume_recent_avg="1173894"
Change_recent_avg="0.01"
Delta_recent_avg="1.16"
Variance_recent_avg="0.58"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="47"
Aroon_momentum_negative="53"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="608"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
